Urispas
formulated to mitigate bladder spasms and frequency.
Strengths: 200mg
Where to Check Availability
Medicine details
- Conditions
- Therapeutic class
Antispasmodic
- Pharmacological class
Antimuscarinic
- Contraindications
gastrointestinal obstruction; myasthenia gravis; urinary tract obstruction
- Precautions and warnings
use with care in elderly patients; may cause dry mouth
- Minor side effects
nausea; dry mouth; drowsiness
- Moderate side effects
blurred vision; tachycardia
- Serious side effects
anaphylaxis — requires immediate medical attention
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Patient summary
formulated to mitigate bladder spasms and frequency.
- Prescription status
POM
- Manufacturer
Recordati
- Onset Time
1–2 hours
- Duration
6–8 hours
- Storage instructions
Store in a cool, dry place.
- Drug interactions
anticholinergic agents
- Age restrictions
Use with caution in elderly patients.
- Pregnancy and breastfeeding
Pregnancy: Use only if clearly necessary. Breastfeeding: Use with caution.
Mechanism of action
Flavoxate acts as a direct smooth muscle relaxant in the bladder, reducing the involuntary contractions associated with frequent urination and urgency.
Urispas
formulated to mitigate bladder spasms and frequency.
Editorial Notes
- Active ingredient(s): Flavoxate
- Listed indication(s): Urinary Frequency, Urinary Urgency
Available option
- 90 tablets - 200 mg385-200-mg-1562